Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec;26(12):7098-7099.
doi: 10.1038/s41380-021-01254-3. Epub 2021 Aug 12.

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

Nicolas Hoertel  1 , Marina Sánchez-Rico  2   3 , Céline Cougoule  4 , Erich Gulbins  5 , Johannes Kornhuber  6 , Alexander Carpinteiro  5   7 , Katrin Anne Becker  5 , Angela M Reiersen  8 , Eric J Lenze  8 , David Seftel  9 , Cédric Lemogne  10 , Frédéric Limosin  2
Affiliations
Comment

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

Nicolas Hoertel et al. Mol Psychiatry. 2021 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

NH, MS-R, EG, JK, AC, and FL are inventors on a patent application related to methods of treating COVID-19, filled by Assistance Publique —Hopitaux de Paris in France. NH has received personal fees and nonfinancial support from Lundbeck, outside the submitted work. AMR and EJL are inventors on a patent application related to methods of treating COVID-19, which was filed by Washington University in St. Louis. EJL has received consulting fees from Johnson and Johnson, and Jazz Pharmaceuticals. AMR has received grant or research support from the McDonnell Center for Systems Neuroscience, the McDonnell Center for Cellular and Molecular Neurobiology, and the Taylor Family Institute for Innovative Psychiatric Research. DS is the Chief Medical Officer and CEO of Enable Biosciences, a CLIA certified Federal clinical reference laboratory that performs COVID-19 antibody testing. CL reports personal fees and nonfinancial support from Janssen-Cilag, Lundbeck, Otsuka Pharmaceutical, and Boehringer Ingelheim, outside the submitted work. FL has received speaker and consulting fees from Janssen-Cilag, Euthérapie-Servier, and Lundbeck, outside the submitted work. Other authors declare no competing interests related to this work.

Comment on

References

    1. Salles J, Briand-Mésange F, Trudel S, Ausseil J, Salles J-P, Chap H. Can antidepressants unlock prescription of rimonabant in the fight against COVID-19? Mol Psychiatry. 2021:1–2. 10.1038/s41380-021-01221-y. Epub ahead of print. - PMC - PubMed
    1. Stip E, Arnone D, Abdel Aziz K, Javaid S. Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties. Mol Psychiatry. 2021:1–5. 10.1038/s41380-021-01222-x. Epub ahead of print. - PMC - PubMed
    1. Hoertel N, Sánchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021. 10.1038/s41380-021-01021-4 Epub ahead of print. - PubMed
    1. Hoertel N, Sánchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. SSRIs and SNRIs and Risk of Death or Intubation in COVID-19: Results from an Observational Study. medRxiv 2020.07.09.20143339; 10.1101/2020.07.09.20143339.
    1. Kornhuber J, Tripal P, Reichel M, Mühle C, Rhein C, Muehlbacher M, et al. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem. 2010;26:9–20. doi: 10.1159/000315101. - DOI - PubMed